Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Irish Stock Exchange  >  Mainstay Medical International PLC    MSTY   IE00BJYS1G50

 SummaryChartsNewsCalendarCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Irish Stock Exchange
10/16/2017 10/17/2017 10/18/2017 10/19/2017 10/20/2017 Date
14.6 14.6 14.6 14.6 14.6 Last
0 0 1000 0 0 Volume
0.00% 0.00% 0.00% 0.00% 0.00% Change
Company
Mainstay Medical International Plc is a medical device company, which is engaged in the development of neurostimulation therapies.The company's focus is on the development of ReActiv8, an innovative implantable medical device designed to treat people with Chronic Low Back Pain.The company was... 
More about the company
Latest news on MAINSTAY MEDICAL INTERNATI
08/03 MAINSTAY : Medical’s ReActiv8-B Clinical Trial Passes Mid-point
06/22 MAINSTAY MEDICAL INTERNATIONAL : to Host Key Opinion Leader Event on the Chronic..
03/23 DGAP-NEWS : Mainstay Medical International Plc
02/02 MAINSTAY MEDICAL INTERNATIONAL : to Present at the 3rd annual Biotech and Money ..
02/01 DGAP-NEWS : Mainstay Medical International Plc: Mainstay Medical beginnt mit dem..
2016 MAINSTAY MEDICAL INTERNATIONAL : Announces Additional U.S. Patent Issued
2016 MAINSTAY MEDICAL INTERNATIONAL : ReActiv8-A Clinical Trial – Sustained Per..
2016 MAINSTAY MEDICAL INTERNATIONAL : 2016 H1 Results Notice
2016 WEBCAST – TUESDAY, 21 JUNE 201 : 30 pm EDT
2016 MAINSTAY MEDICAL : Achieves CE Marking for ReActiv8®
More news
Sector news : Bio Medical Devices
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Bio Medical Devices
Chart MAINSTAY MEDICAL INTERNATI
Duration : Period :
Mainstay Medical Internati Technical Analysis Chart | MSTY | IE00BJYS1G50 | 4-Traders
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price -
Spread / Average Target -100%
Managers
NameTitle
Jason M. Hannon Chief Executive Officer & Director
Peter Andrew Crosby President & Director
Oern Reidar Stuge Independent Non-Executive Chairman
Prashant Rawat Chief Operating Officer
Hugh Kavanagh Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
MAINSTAY MEDICAL INTERNATIONAL PLC2.82%114
GILEAD SCIENCES11.73%106 054
REGENERON PHARMACEUTICALS19.69%46 395
VERTEX PHARMACEUTICALS110.07%38 985
ACTELION23.81%29 840
INCYTE CORPORATION13.96%24 054